Provided by Tiger Trade Technology Pte. Ltd.

Biohaven Pharmaceutical Holding Co Ltd.

11.93
+0.05000.42%
Pre-market: 12.330.4025+3.37%05:34 EDT
Volume:2.70M
Turnover:31.91M
Market Cap:1.79B
PE:-2.66
High:12.12
Open:11.83
Low:11.46
Close:11.88
52wk High:18.57
52wk Low:7.48
Shares:150.42M
Float Shares:117.99M
Volume Ratio:1.33
T/O Rate:2.29%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.4800
EPS(LYR):-6.8648
ROE:-799.46%
ROA:-71.98%
PB:146.82
PE(LYR):-1.74

Loading ...

Biohaven - Dosing Continues for over 600 Randomized Patients in Bhv-7000 Program - SEC Filing

THOMSON REUTERS
·
Sep 10

Biohaven - FDA Issues Partial Clinical Hold Pausing New Enrollment for Bhv-7000 on Sept 4, 2026 - SEC Filing

THOMSON REUTERS
·
Sep 10

FDA Places Partial Clinical Hold on Biohaven BHV-7000 Epilepsy Trial, Halting New Enrollment

Reuters
·
Sep 10

U.S. Stocks on the MOVE-Best Buy, Peloton, Apple

Reuters
·
Sep 09

Biohaven Stock Seen Range-Bound as Near-Term Catalysts Fade, RBC Says

MT Newswires Live
·
Sep 09

U.S. Stocks on the MOVE-Sigma Lithium, Shake Shack, Novartis

Reuters
·
Sep 08

RBC Downgrades Biohaven to Sector Perform From Outperform, Cuts Price Target to $19 From $23, Keeps Speculative Risk

MT Newswires Live
·
Sep 08

RBC Downgrades Biohaven to 'sector Perform', Shares Fall

Reuters
·
Sep 08

Biohaven Ltd. : RBC Cuts to Sector Perform from Outperform; Cuts Target Price to $19 from $23

THOMSON REUTERS
·
Sep 08

U.S. Research Roundup-Fedex Freight Holding Company, PDF Solutions, Robinhood Markets

Reuters
·
Sep 08

Is Biohaven (BHVN) A Bargain On Its SK Biopharma Licensing Deal?

Simply Wall St.
·
Aug 31

Update: Biohaven Shares Rise After Epilepsy Drug Licensing Deal

MT Newswires Live
·
Aug 27

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Gossamer Bio (GOSS) and Biohaven Ltd. (BHVN)

TIPRANKS
·
Aug 27

H.C. Wainwright says Biohaven license agreement buys time, ‘not a solution’

TIPRANKS
·
Aug 27

Biohaven rises 10.8%

TIPRANKS
·
Aug 27

Biohaven Shares Gain 5% on SK Biopharma Epilepsy Licensing Deal Worth up to $795 Million

THOMSON REUTERS
·
Aug 26

U.S. Stocks on the MOVE-Semtech, Donaldson, Meta

Reuters
·
Aug 26

Delaware Court Enters USD 4 Million Judgment for Biohaven, Yale in Trade Secret Case Against RA Capital, Avilar

Reuters
·
Aug 26

Biohaven to receive $400M in SK Biopharmaceuticals licensing, collaboration pact

TIPRANKS
·
Aug 26

Biohaven Licenses Kv7 Epilepsy Drug Platform to SK Biopharmaceuticals in Deal Worth up to USD 795 Million

Reuters
·
Aug 26